PTGX

Keeping an Eye on ALLO, SYRS, PTGX, AUTL, and IMRA in Light of Biotech Catalysts; Disclosure Updates
Gallery
Keeping an Eye on ALLO, SYRS, PTGX, AUTL, and IMRA in Light of Biotech Catalysts; Disclosure Updates

Bill Langbein, SanaCurrents, SanaCurrents Updates

Keeping an Eye on ALLO, SYRS, PTGX, AUTL, and IMRA in Light of Biotech Catalysts; Disclosure Updates

By Bill Langbein|2020-12-07T11:59:23-05:00December 7th, 2020|Categories: Bill Langbein, SanaCurrents, SanaCurrents Updates|Tags: ALLO, AUTL, IMRA, PTGX, SYRS|

Clinical data findings related to five SanaCurrents catalysts will be [...]

0

SanaCurrents Pivotal Sentiment on Protagonist (PTGX) polycythemia vera phase II trial
Gallery
SanaCurrents Pivotal Sentiment on Protagonist (PTGX) polycythemia vera phase II trial

Bill Langbein, SanaCurrents, SanaCurrents Probability Sentiment

SanaCurrents Pivotal Sentiment on Protagonist (PTGX) polycythemia vera phase II trial

By Bill Langbein|2020-11-17T10:15:51-05:00November 14th, 2020|Categories: Bill Langbein, SanaCurrents, SanaCurrents Probability Sentiment|Tags: PTGX|

Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Probability Sentiment [...]

0